Ruchi Chandrakant Rana, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-512-8951 |
Rachel Wiberg, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 335 Orange St Apt 501, New Haven, CT 06511 Phone: 203-470-3249 |
Richard Wurtzel Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 York St Apt 14d, New Haven, CT 06511 Phone: 203-605-7229 |
Lynn M Acton, MS Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave, Yale Physicians Building-4th Fl, New Haven, CT 06519 Phone: 203-785-2593 Fax: 203-785-5936 |
Aleeza Sarah Zeiger Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 122 Hubinger St Fl 3, New Haven, CT 06511 Phone: 203-232-3069 |
John Patrick Gerrity Jr., MA, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave Fl 4, New Haven, CT 06519 Phone: 203-785-5430 |
Eva Montas Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 118 Clinton Ave, New Haven, CT 06513 Phone: 860-840-0861 |
Rhea Paul, PHD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 Howard Ave, Yale Physicians Bldg, New Haven, CT 06519 Phone: 203-785-2140 Fax: 203-785-6414 |
Christiana Moustakas O'hara, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1450 Chapel St, New Haven, CT 06511 Phone: 508-735-6270 |
Amy Marie Levine, MS CCC SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1450 Chapel St, New Haven, CT 06511 Phone: 203-789-3362 |
Jennifer Marie Hamrin Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 915 Ella T Grasso Blvd, New Haven, CT 06519 Phone: 203-865-5155 |
Virginia Mcgoey-radshaw, M.ED. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 357 Whitney Ave, Suite 103, New Haven, CT 06511 Phone: 203-773-0665 |
Ms. Alida Engel, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 Edgewood Ave, New Haven, CT 06515 Phone: 203-397-3224 |
Janice Hall Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 Columbus Ave, New Haven, CT 06519 Phone: 203-503-3250 Fax: 203-503-3297 |
Alexa Cometz Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 |
Ashley Macri Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Long Wharf Dr Ste 202, New Haven, CT 06511 Phone: 203-688-6967 |
Dina Gorlick Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 226 Dixwell Ave, New Haven, CT 06511 Phone: 203-503-3441 |
Harriet Barba Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 226 Dixwell Ave, New Haven, CT 06511 Phone: 203-503-3440 Fax: 203-786-6586 |
Holly Reis Linardy, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Long Wharf Dr Ste 202, New Haven, CT 06511 Phone: 203-688-8872 Fax: 203-688-4542 |
Denise Rini Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 226 Dixwell Ave, New Haven, CT 06511 Phone: 203-505-3441 |
News Archive
Researchers of H5N1 bird flu virus "are set to wrap up a two-day meeting on the issue Friday with international experts at the World Health Organization in Geneva" with the aim of settling controversy over the work of two research teams that created genetically altered viral strains that are easily transmissible among ferrets, a laboratory model for humans, the Associated Press reports (Mason, 2/17).
Imagine that the movement of a single hair on your arm causes severe pain. For patients with neuropathic pain - a chronic illness affecting 7 to 8% of the European population, with no effective treatment - this can be a daily reality.
The U.S. Food and Drug Administration has approved tetrabenazine, the first drug approved for use in the United States to treat Huntington's disease, a fatal, inherited neurodegenerative disorder for which there is no cure. The action comes about eight months after an advisory panel unanimously voted to advise FDA to make the medication available to treat the disease.
Scientists investigating the interactions, or binding patterns, of a major tumor-suppressor protein known as p53 with the entire genome in normal human cells have turned up key differences from those observed in cancer cells. The distinct binding patterns reflect differences in the chromatin (the way DNA is packed with proteins), which may be important for understanding the function of the tumor suppressor protein in cancer cells.
Researchers at the University of North Carolina at Chapel Hill School of Medicine have identified a compound that could be modified to treat one of the most deadly types of cancer, and discovered how a particular gene mutation contributes to tumor growth.
› Verified 1 days ago